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Abstract 
Aims: Partial pressure of arterial carbon dioxide (PaCO2) is a regulator of cerebral blood 
flow after brain injury. We sought to test the association between PaCO2 after 
resuscitation from cardiac arrest and neurological outcome. 
Methods: A prospective protocol-directed cohort study across six hospitals. Inclusion 
criteria:  age ≥ 18, non-traumatic cardiac arrest, mechanically ventilated after return of 
spontaneous circulation (ROSC), and receipt of targeted temperature management. Per 
protocol, PaCO2 was measured by arterial blood gas analyses at one and six hours after 
ROSC. We determined the mean PaCO2 over this initial six hours after ROSC. The 
primary outcome was good neurological function at hospital discharge, defined a priori 
as a modified Rankin Scale ≤ 3. Multivariable Poisson regression analysis was used to 
test the association between PaCO2 and neurological outcome. 
Results: Of the 280 patients included, the median (interquartile range) PaCO2 was 44 
(37-52) mmHg and 30% had good neurological function. We found mean PaCO2 had a 
quadratic (inverted “U” shaped) association with good neurological outcome, with a 
mean PaCO2 of 68 mmHg having the highest predictive probability of good neurological 
outcome, and worse neurological outcome at higher and lower PaCO2. Presence of 
metabolic acidosis attenuated the association between PaCO2 and good neurological 
outcome, with a PaCO2 of 51 mmHg having the highest predictive probability of good 
neurological outcome among patients with metabolic acidosis. 
Conclusion: PaCO2 has a “U” shaped association with neurological outcome, with mild to 
moderate hypercapnia having the highest probability of good neurological outcome.  
 
Word count: 246 
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Introduction 
Post-cardiac arrest syndrome is a devastating condition,[1, 2] with an associated 
mortality rate of over 50%. Among those that survive, many are left with permanent, 
disabling neurological injury.[3] To date there are few interventions shown to improve 
outcome after cardiac arrest.[4] One such potential therapy is manipulation and titration 
of gas exchange during mechanical ventilation.[5, 6]  
 
Current post-resuscitation guidelines recommend titrating minute ventilation in post-
cardiac arrest patients to maintain normocapnia [i.e. partial pressure of arterial carbon 
dioxide (PaCO2) 35-45 mmHg].[7-9] However, it is currently unclear if normocapnia is the 
optimal PaCO2 range. PaCO2 is a major regulator of cerebral blood flow after brain 
injury.[10-13] Hypocapnia has been postulated to exacerbate brain injury by inducing 
cerebral vasoconstriction, decreased cerebral blood flow, and increased cerebral 
ischemia. [10, 11, 13] Alternatively hypercapnia induces cerebral vasodilation. This 
increase in cerebral vasodilation could be harmful by increasing intracranial volume with 
a potential increase in intracranial pressure and decreased cerebral perfusion.[5, 14, 15]  
However, mild hypercapnia, could result in mild cerebral vasodilation leading to 
improved cerebral blood flow and oxygen delivery, thereby reducing neuronal injury.[16, 
17] While observational studies have consistently found hypocapnia to be associated 
with poor clinical outcomes after cardiac arrest,[5, 18-20] studies examining hypercapnia 
have conflicting results. Some studies have found hypercapnia to be associated with 
poor clinical outcomes,[5, 21] while others have suggested mild hypercapnia could 
potentially improve clinical outcomes after cardiac arrest.[19, 22] By their design, these 
previous studies have methodological limitations (e.g. measurement bias). Specifically, 
they were primarily retrospective in design and relied on arterial blood gas (ABG) results 
ordered at the discretion of treating physicians, as opposed to protocol-directed ABG 
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measurements at pre-specified time points. In addition, they used arbitrary cut points, 
which differed between studies, to define PaCO2 ranges as opposed to analyzing the full 
spectrum of PaCO2 as a continuous variable. Categorizing a continuous variable has 
several disadvantages including a loss of information.[23] We therefore conducted this 
study to address the existing limitations in the data. 
 
The objective of this prospective multicenter protocol-directed cohort study was to test 
the association between early PaCO2 after resuscitation from cardiac arrest and 
neurological outcome. Based on previous post-cardiac arrest studies, we hypothesized 
that PaCO2 has a quadratic (“U” shaped) association with neurological outcome,[5, 21] 
and that a PaCO2 above the physiological normal range (i.e. mild hypercapnia) is 
associated with the highest probability of good neurological outcome.[19, 22]  
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Methods 
Setting 
We performed a prospective protocol-directed cohort study across six academic 
hospitals in the United States. The Institutional Review Board at each participating 
institution approved this study. This study is reported in accordance with the 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
Statement.[24] 
 
Participants  
We included adult post-cardiac arrest patients who were comatose (defined as a 
Glasgow coma scale motor score < 6) after ROSC between 2013-2017.  The inclusion 
criteria were: 1) age ≥ 18 years; 2) cardiac arrest, defined as a documented absence of 
pulse and initiation of cardiopulmonary resuscitation (CPR); 3) ROSC > 20 min; 4) 
mechanically ventilated after ROSC; and 5) clinician commitment to perform targeted 
temperature management.  We decided a priori to include patients with both in- and out-
of-hospital cardiac arrest, as this would generate a pragmatic study whose results could 
be broadly applicable to as many cardiac arrest patients as possible. We excluded 
patients with presumed etiology of arrest secondary to trauma, hemorrhage or sepsis; 
resident of a nursing home or other long-term care facility; pregnancy; prisoners; and 
terminal illness with no reasonable expectation to survive to hospital discharge or known 
lack of commitment to aggressive support by next of kin. We also excluded patients who 
died prior to an arterial blood gas analysis being obtained. 
 
Data Collection 
As part of our research protocol we obtained an initial ABG one-hour after ROSC and a 
second ABG six hours after ROSC (plus or minus two hours). We also recorded all 
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additional ABG analyses ordered by the treating physician. See Supplemental Methods 
for information on additional data collection.  
 
Outcome measures 
The primary outcome was good neurological function at hospital discharge, defined a 
priori as a modified Rankin Scale (mRS) ≤ 3.[25] The mRS was prospectively 
determined for each patient at the time of hospital discharge. All raters were trained and 
certified in mRS assessment [26] and used a structured questionnaire and interview, 
which have been shown to produce very good interobserver reliability.[27, 28]   
 
Data Analysis 
We began the analysis with descriptive statistics. We used t-test or Wilcoxon rank-sum 
test to compare continuous variables, based on the distribution of the data, and chi-
square test or Fisher exact test to compare categorical variables.  
 
For purposes of analysis we determined the mean PaCO2 values over the initial six 
hours after ROSC. We chose the initial six-hour period after ROSC as this time period 
has been postulated to be when the brain is most likely susceptible to additional 
reperfusion injury.[6, 29] Our primary analysis aimed to test the relationship between 
mean PaCO2 levels and neurological outcome. Multivariable Poisson regression analysis 
with robust standard error was used to calculate relative risk with 95% confidence 
intervals (CI) [30] for good neurological outcome entering PaCO2 as a continuous 
variable calibrated for a rise in 5 mmHg. Based on previous post-cardiac arrest 
studies,[5, 21] we a priori hypothesized a quadratic (“U” shaped) association between 
PaCO2 and neurological outcome (i.e. hypocapnia and severe hypercapnia would both 
be associated with worse neurological outcome). Therefore, we entered an interaction 
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term between mean PaCO2 and itself (i.e. PaCO2 squared) into the model in order to 
identify if a turning point exists in the association between PaCO2 and neurological 
outcome. The coefficient for this interaction term describes the change in the association 
between PaCO2 and good neurological outcome as PaCO2 increases (i.e. nonlinear 
relationship). See Supplemental Methods for full description of the model. 
Using our final model we calculated predicted probabilities with 95% CI for good 
neurological outcome across the spectrum of mean PaCO2 and graphed the results. We 
used the predicted probabilities to identify the PaCO2 levels with the highest probability 
for good neurological outcome.  
 
We performed several a priori planned sensitivity analyses. First, we entered additional 
covariates beyond those pre-specified into our model. Second, we forced exposure to 
tidal volume greater than 8 mL/kg PBW during the initial six hours after ROSC, and 
history of chronic pulmonary disease into our model. Third, we performed an a priori 
subgroup analysis limited to patients with a metabolic acidosis. Finally, given as PaCO2 
increases, arterial pH decreases we performed an ad hoc analysis to test if pH also has 
a quadratic association with good neurological outcome (see Supplemental Methods 
for full description of sensitivity analyses).  
 
It is possible that extreme PaCO2 levels reflect patient populations that are more ill and 
thus more likely to have poor neurological outcome. To detect if mean PaCO2 was a 
marker for severity of illness we used ordered logistic regression to test if mean PaCO2 
is a predictor of the six-hour Sequential Organ Failure Assessment (SOFA) score (see 
Supplemental Methods). 
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Protocol amendment 
The initial protocol for this study stated a primary outcome of poor neurological outcome 
defined as a modified Rankin scale (mRS) ≥ 3. In order to make the outcome consistent 
with parallel cardiac arrest studies (clinicaltrials.gov identifiers NCT01881243 and 
NCT02698826), and for easier interpretation of the results, the primary outcome was 
changed to good neurological outcome defined as a mRS ≤ 3. The investigators were 
blinded to all data at the time of this change, which occurred in February 2016, two years 
before any data analysis for this study began.  
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Results 
Two hundred and eighty subjects met all inclusion and no exclusion criteria (exclusion 
flow diagram previously published).[31] The median [interquartile range (IQR)] mean 
PaCO2 for the entire cohort was 44 (37-52) mmHg. The distribution of mean PaCO2 is 
displayed in Supplemental Figure 1. The median (IQR) time to first ABG was 59 (35-
103) min. 
 
Table 1 displays baseline data for all subjects in the cohort. The most common type of 
cardiac arrest was out-of-hospital cardiac arrest with PEA/asystole as the initial rhythm 
[109/280 (39%)] and few patients were in-hospital with pulseless VT/VF as the initial 
rhythm [17/280 (6%)]. Table 2 displays post-cardiac arrest data for all subjects. Several 
additional variables were found to be associated with neurological outcome on 
univariable analysis: fraction of inspired oxygen (FiO2), positive end expiratory pressure 
(PEEP), history of congestive heart failure, prescribed respiratory rate and minute 
ventilation, airway plateau pressure, arterial pH, vasopressor use, and Charlson 
comorbidity index. CPR downtime was missing for four (1%) patients and mean plateau 
pressure was available for 85% of patients.  
 
We did not find PaCO2 to be a marker for severity of illness [linear: odds ratio, 1.04 (95% 
CI 0.97 - 1.11); quadratic: PaCO2 odds ratio 1.10 (95% CI 0.79 - 1.52), PaCO2 squared 
odds ratio 1.00 (0.98 - 1.01)]. The overall in-hospital mortality of the entire cohort was 
55%.  
 
Thirty percent of subjects had the primary outcome of good neurological function at 
hospital discharge. Table 3 displays the results of the multivariable Poisson regression 
model for good neurological outcome. We found PaCO2 to have a quadratic association 
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with good neurological outcome, relative risk for 5 mmHg rise in PaCO2, 1.50 (95% CI 
1.35-1.65), and PaCO2 squared 0.99 (95% CI 0.99 - 0.99). These data suggest a 50% 
increase in the probability of good neurological outcome for every 5 mmHg increase in 
PaCO2; however, the relative risk for PaCO2 squared less than one suggests this 
association decreases as PaCO2 increases. We found PaCO2 squared significantly 
improved the fit of the model (Wald test p < 0.001). We found our results remained 
essentially unchanged after using multiple imputation by chained equations to impute 
missing co-variables (Supplemental Table 1). Figure 1 displays the predicted 
probabilities for good neurological outcome by mean PaCO2. The probability of good 
neurological outcome increases until a mean PaCO2 of 68 mmHg after which point the 
probability of good neurological begins to decrease. We did not find adjusting our model 
for addition co-variables, including hyperoxia and exposure to tidal volume > 8 cc/kg 
PBW, significantly changed our results (Supplemental Tables 2 and 3).  
 
On subgroup analysis of patients with metabolic acidosis, we found PaCO2 had a 
quadratic association with good neurological outcome, relative risk for 5 mmHg rise in 
PaCO2, 1.80 (95% CI 1.24 - 2.60), and PaCO2 squared 0.97 (95% CI 0.95 - 0.99) 
(Supplemental Table 4). Figure 2 displays the predicted probabilities for good 
neurological outcome by mean PaCO2 among patients with metabolic acidosis. The 
probability of good neurological outcome increases until a mean PaCO2 of 51 mmHg at 
which point the probability of good neurological outcome begins to decrease.  
 
We found mean arterial pH to have a quadratic association with good neurological 
outcome, relative risk for 0.01 rise in pH, 4.24 (95% CI 1.76-9.57), and pH squared 0.99 
(95% CI 0.99 - 0.99). Figure 3 displays the predicted probabilities for good neurological 
outcome by mean arterial pH. The probability of good neurological outcome increases as 
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pH decreases until a pH of 7.19 after which point as the pH continues to decrease the 
probability of good neurological begins to decrease. 
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Discussion 
In this prospective, multi-center study, using a standardized protocol for ABG 
measurements, we tested whether PaCO2 exposure after resuscitation from cardiac 
arrest was associated with neurological function at hospital discharge. We found that 
PaCO2 has an inverted “U” shaped association with good neurological outcome, with 
increasing probability of good neurological outcome as PaCO2 increases up to 68 
mmHg. Our results suggest a mild to moderate degree of hypercapnia is associated with 
improved neurological outcome. These results remained consistent even after adjusting 
for confounders previously associated with outcome in cardiac arrest patients, including 
the use of a lung protective ventilation strategy.  
 
As expected we found the presence of a metabolic acidosis to attenuate the association 
between PaCO2 and neurological outcome, with the highest probability of good 
neurological outcome occurring at a lower PaCO2 among patients with a metabolic 
acidosis (i.e. metabolic acidosis shifts the quadratic curve to the left). It is reasonable to 
infer from these results that the quadratic association between PaCO2 and neurological 
outcome is at least partially influenced by arterial pH. As PaCO2 increases it may lower 
the arterial pH to a point at which the harmful effects of acidemia negate any potential 
benefit from hypercapnia. As we found, this point would be expected to occur at a lower 
PaCO2 in the setting of a concomitant metabolic acidosis given an elevated PaCO2 
typically results in a lower arterial pH in the setting of a concomitant metabolic acidosis 
compared to a similar PaCO2 level in a patient without a concomitant metabolic acidosis. 
This is further supported by our results, which found the probability of good neurological 
outcome to increase as arterial pH decreases to 7.19, below which probability of good 
neurological outcome begins to decrease. This suggests allowing hypercapnia up to a 
PaCO2 of 68 mmHg or until pH decreases to 7.19 may be a potential therapeutic target.  
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Our finding of a quadratic association between PaCO2 and neurological outcome has 
biological plausibility. PaCO2 is a major regulator of cerebral blood flow after brain 
injury.[12] Thus, hypocapnia may induce cerebral vasoconstriction resulting in 
decreased cerebral blood flow and increased cerebral ischemia potentially exacerbating 
anoxic brain injury.[10, 11, 13] Alternatively, hypercapnia may decrease cerebrovascular 
resistance and increase blood flow, offering a potential benefit in patients suffering from 
ischemic brain injury.[11, 32] Consistent with our findings, a recent study of post-cardiac 
arrest subjects found induced mild hypercapnia during the early post-resuscitation period 
resulted in increased cerebral tissue oxygen saturation compared to normocapnia.[17] A 
small feasibility randomized control trial of mild hypercapnia versus normocapnia among 
post-cardiac arrest patients found mild hypercapnia attenuated the rise in neuron-
specific enolase (a serum biomarker for neuronal injury), but not S100b protein (a 
biomarker of glial injury).[16] In addition to potential cerebrovascular benefits, 
hypercapnia has also been demonstrated to decrease key components of inflammatory 
pathways,[33, 34] and is associated with survival to hospital discharge among patients 
with sepsis-induced respiratory failure requiring mechanical ventilation.[31]  
 
Although mild to moderate hypercapnia may induce improvement in cerebral blow flood 
and potentially confer benefit, it remains possible that severe hypercapnia could result in 
excessive cerebral vasodilation resulting in increased intracranial pressure and 
decreased cerebral perfusion, thus conferring harm.[14, 15] In addition, severe 
hypercapnia can result in a significant arterial acidosis, which may be harmful. On 
univariable analysis we found lower arterial pH to be associated with poor neurological 
outcome. However, when adjusted for PaCO2 and metabolic acidosis in our sensitivity 
model, arterial pH was no longer found to be associated with neurological outcome, 
suggesting pH may be on the causal pathway. In addition, when we tested arterial pH in 
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our model without PaCO2 we found an arterial pH below 7.19 was associated with 
decreased probability of good neurological outcome. These results are also supported 
by recent studies of non-cardiac arrest patients with acute respiratory distress syndrome 
admitted to the intensive care unit, which found severe hypercapnia to be independently 
associated with in-hospital mortality.[35, 36] 
 
This current study has several strengths. First, to our knowledge this is the first fully 
prospective, multi-center study using protocol-directed ABG measurements in the early 
hours following resuscitation, as well as protocol-directed assessments of neurological 
disability, testing the association between PaCO2 and neurological outcome. Second, we 
tested PaCO2 as a continuous variable as opposed to using arbitrary cut points to define 
PaCO2 ranges. Categorizing a continuous variable has several important disadvantages; 
there is a loss of information and statistical power, as well as potential concealment of 
any non-linear relationships between the variable and outcome.[23] Thus, by keeping 
PaCO2 as a continuous variable we were able to identify its quadratic relationship with 
neurological outcome. Third, previous studies did not investigate the interaction between 
PaCO2 and metabolic acidosis. In this study we found metabolic acidosis to be an 
important effect modifier of the relationship between PaCO2 and neurological outcome, 
which could help explain the conflicting results between previous studies. Our findings 
demonstrating a “U” shaped relationship between PaCO2 and neurological outcome are 
consistent with our previous work as well as results from studies of multiple forms of 
cerebral injury (e.g. traumatic brain injury, post-cardiac arrest syndrome, and stroke).[5, 
37]  
 
We acknowledge that this study has important limitations to consider.  First, this was an 
observational study and thus we can only report association rather than infer causation. 
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Specifically, we are unable to determine if hypocapnia and severe hypercapnia cause 
harm or are the result of an intrinsic characteristic of the subject (e.g. more acidotic 
patients having an increased intrinsic respiratory rate resulting in lower PaCO2 or more 
severe lung injury resulting in higher PaCO2). However, our results remained consistent 
after adjusting for metabolic acidosis, alveolar dead space, and airway plateau pressure. 
In addition, we found important differences in patient characteristics, such as age, initial 
rhythm, and duration of CPR between patients with good vs. poor neurologic outcome; 
however, our results remained consistent after adjusting for these variables. Second, 
unlike Beitler, et al, we did not find lower tidal volumes to be associated with improved 
neurological outcome.[38] However, this previous study tested the association between 
tidal volume over the first 48 hours after ROSC, while we adjusted our model for the tidal 
volume over the first six hours (time frame of PaCO2 exposure tested). The presumed 
mechanism by which higher tidal volumes causes cerebral injury is through mechanical 
lung injury that propagates systemic inflammation.[38] It is possible that the development 
of this systemic inflammation requires a prolonged time at high tidal volumes (i.e. greater 
than six hours). Alternatively, higher PaCO2 levels, secondary to lower tidal volumes, 
may account for some of the association previously found between lower tidal volumes 
and improved neurological outcome. Third, in contrast to some resuscitation clinical 
investigations we a priori decided to include patients with both in- and out-of-hospital 
cardiac arrest. We felt this was warranted to allow for a more pragmatic study, in which 
the results can be applicable to the largest possible patient population. It is possible that 
there were unmeasured confounders such as time to initiation of CPR and quality of 
basic life support in the out-of-hospital setting. However, in this study, arrest location 
was not associated with outcome and PaCO2 remained an independent predictor of 
neurological outcome after adjusting for cardiac arrest location.  Fourth, it remains 
possible that hypocapnia and severe hypercapnia reflect patient populations that are 
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more ill and thus more likely to have poor neurological outcome. However, we did not 
find PaCO2 to be associated with the six-hour SOFA score, which suggests this is not 
the case. 
 
Conclusion 
In summary, PaCO2 has a quadratic association with neurological outcome, with mild to 
moderate hypercapnia having the highest predicted probability for good neurological 
outcome. Randomized controlled trials are warranted to further determine whether 
manipulation of PaCO2 to target mild hypercapnia after resuscitation from cardiac arrest 
improves outcomes. 
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Figure 1: Predicted probability* of good neurological function at hospital discharge 
[defined as a modified Rankin Scale (mRS) ≤ 3 at hospital discharge] in relation to mean 
partial pressure of arterial carbon dioxide (PaCO2) during the first six hours after return 
of spontaneous circulation. Shaded area, 95% confidence intervals. 
 
*Predicted probabilities calculated using Poisson regression model with robust standard 
errors adjusting for initial cardiac arrest rhythm, age, airway dead space (corrected 
minute ventilation for normal PaCO2), metabolic acidosis (yes/no), mean arterial blood 
pressure, and percutaneous coronary intervention (yes/no). 
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Figure 2: Predicted probability* of good neurological function at hospital discharge 
[defined as a modified Rankin Scale (mRS) ≤ 3 at hospital discharge] in relation to mean 
partial pressure of arterial carbon dioxide (PaCO2) during the first six hours after return 
of spontaneous circulation among patients with a metabolic acidosis (defined as one or 
more recorded base deficit ≤ -6 during the initial six hours after ROSC). Shaded area, 
95% confidence intervals. 
 
*Predicted probabilities calculated using Poisson regression model with robust standard 
errors adjusting for initial cardiac arrest rhythm, age, airway dead space (corrected 
minute ventilation for normal PaCO2), mean arterial blood pressure, and percutaneous 
coronary intervention (yes/no). 
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Figure 3: Predicted probability* of good neurological function at hospital discharge 
[defined as a modified Rankin Scale (mRS) ≤ 3 at hospital discharge] in relation to mean 
arterial pH during the first six hours after return of spontaneous circulation. Shaded area, 
95% confidence intervals. 
 
*Predicted probabilities calculated using Poisson regression model with robust standard 
errors adjusting for initial cardiac arrest rhythm, age, airway dead space (corrected 
minute ventilation for normal PaCO2), metabolic acidosis (yes/no), mean arterial blood 
pressure, and percutaneous coronary intervention (yes/no). 
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Table 1: Baseline data for all subjects at the time of cardiac arrest.  
 
* Defined as a Modified Rankin Scale ≤ 3 at hospital discharge. † Defined as a Modified 
Rankin Scale > 3 at hospital discharge.  
BMI, body mass index; CPR, cardiopulmonary resuscitation; IQR, interquartile range; 
mRS, modified Rankin Scale; PEA, pulseless electrical activity; SD, standard deviation; 
VF, ventricular fibrillation; VT ventricular tachycardia  
 
 
Variable 
 
 
All Subjects 
 
 
n = 280 
 
Good 
Neurological 
Outcome* 
 
n = 85 
 
Poor 
Neurological 
Outcome† 
 
n = 195 
 
 
p-value 
Age [years (SD)] 59 (15) 55 (13) 60 (15) 0.002 
Female gender [n (%)] 101 (36) 33 (39) 29 (35) 0.527 
BMI [median (IQR)] 29 (24-34) 30 (24-32) 30 (25-34) 0.553 
Pre-existing comorbidities  [n (%)]     
     Diabetes  68 (24) 20 (24) 48  (25) 0.846 
     Known coronary artery disease  75 (27) 20 (24) 55 (28) 0.417 
     Hypertension  183 (65) 51 (60) 132 (68) 0.214 
     Malignancy  20 (7) 4 (4) 16 (8) 0.449 
     Renal insufficiency  43 (15) 10 (12) 33 (17) 0.271 
     Pulmonary disease  65 (23) 15 (18) 50 (26) 0.145 
     Cerebral vascular disease  24 (9) 6 (7) 18 (9) 0.551 
     Congestive heart failure  69 (25) 14 (16) 55 (28) 0.036 
Charleson comorbidity score 1 (0-3) 1 (0-2) 1 (0-3) 0.005 
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Arrest location  [n (%)]     
     Out-of-hospital  216 (77) 68 (80) 148 (76) 0.452 
     In-hospital  64 (23) 17 (20) 47 (24)  
Initial arrest rhythm  [n (%)]     
     PEA/asystole  154 (55) 27 (32) 127 (65)  
     VF/VT  
     Unknown 
103 (37) 
23 (8) 
49 (58) 
9 (11)  
54 (28) 
 
14 (7) 
<0.001 
CPR duration [median (IQR)] 15 (8-23) 10 (5-17) 17 (9-28) <0.001 
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Table 2: Post-cardiac arrest data for all subjects. All values are median (interquartile 
range) unless otherwise noted. 
 
Continuous variables reported are the mean value for each subject over the initial six 
hours after return of spontaneous circulation. *Defined as a Modified Rankin Scale ≤ 3 at 
hospital discharge. †Defined as a Modified Rankin Scale > 3 at hospital discharge. 
‡Exposure to a set tidal volume > 8 cc/kg PBW at any point during this initial six hours 
after return of spontaneous circulation. §Defined as exposure to PaO2 > 300 mmHg on at 
least one arterial blood gas during the initial six hours after ROSC. **Estimated using 
corrected minute ventilation for normal partial pressure of arterial carbon dioxide. 
††Defined as a base deficit ≤ -6 on one or more arterial blood gas analyses during the 
first six hours after return of spontaneous circulation. ‡‡Defined as exposure to mean 
arterial pressure < 70 mmHg during the initial six hours after ROSC  
FiO2, fraction of inspired oxygen; PaCO2, partial pressure of arterial carbon dioxide; 
PaO2, partial pressure of arterial oxygen; PBW, predicted body weight; PEEP, positive 
end expiratory pressure; MAP, mean arterial blood pressure; PCI, percutaneous 
coronary intervention; SOFA, sequential organ failure assessment. 
 
 
Variable 
 
 
All Subjects 
 
 
n = 280 
 
Good 
Neurological 
Outcome* 
 
n = 85 
 
Poor 
Neurological 
Outcome† 
 
n = 195 
 
 
p-value 
Ventilator parameters     
     FiO2 0.82  
(0.66-0.97) 
 
0.78  
(0.60-0.95) 
0.84 
(0.68-0.98) 
0.077 
     PEEP (cmH2O) 5 (5-7) 5 (5-5) 5 (5-7) 0.043 
     Set tidal volume (cc/kg PBW) 7.4 (6.7-8.1) 7.5 (6.8-8.1) 7.3 (6.7-8.1) 0.813 
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     Set tidal volume > 8 cc/kg PBW‡  
     [n (%)] 
 
91 (34) 26 (31) 65 (35) 0.483 
     Set respiratory rate (breaths/min) 17 (15-20) 16 (14-18) 18 (15-21) <0.001 
     Set minute ventilation (cc/kg*min) 125  
(106-153) 
 
120  
(105-137) 
129 
(106-166) 
0.015 
     Plateau airway pressure (cmH2O) 20 (16-25) 19 (16-22) 22 (17-26) 0.004 
PaO2 
 
175  
(109-268) 
157  
(108-254) 
177  
(109-274) 
0.194 
PaO2/FiO2 ratio 237  
(145-337) 
 
237  
(153-299) 
237  
(142-348) 
0.665 
Hyperoxia§ [n (%)] 105 (38) 24 (28) 81 (42) 0.034 
Alveolar dead space** (l/min) 9 (7-12) 8 (7-10) 10 (7-12) 0.003 
Arterial pH 7.27  
(7.18-7.34) 
 
7.28 
(7.22-7.36) 
7.26 
(7.17-7.33) 
0.007 
Base deficit -7 (-11- -3) -6 (-10 to -2) -8 (-12 to -4) 0.009 
Metabolic acidosis†† [n (%)] 202 (72) 49 (58) 153 (78) <0.001 
MAP (mmHg) 94 (82-105) 100 (91-109) 89 (81-101) <0.001 
Hypotension‡‡ [n (%)] 142 (51) 27 (32) 115 (59) <0.001 
Vasopressor infusion [n (%)] 148 (53) 30 (35) 118 (61) <0.001 
PCI [n (%)] 31 (11) 15 (18) 16 (8) 0.021 
Time to target temperature (min) 166 (73-257) 170 (90-285) 155 (70-241) 0.256 
Modified SOFA score 7 (5-10) 7 (5-10) 7 (5-10) 0.408 
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Table 3: Multivariable Poisson regression model with good neurological outcome 
[defined as modified Rankin Scale (mRS) ≤ 3 at hospital discharge] as the dependent 
variable. Mean partial pressure of arterial carbon dioxide (PaCO2) during the initial six 
hours after return of spontaneous circulation entered as a continuous variable calibrated  
for rise in 5 mmHg. 
 
*Calibrated for a rise in 10 years; †Estimated using corrected minute ventilation for 
normal PaCO2. ‡Defined as a base deficit ≤ -6 during the first 6 hours after return of 
spontaneous circulation. 
CI, confidence interval; VT/VF, ventricular tachycardia/ventricular fibrillation. 
Model has good fit: Deviance test p = 1 
Removed for non-significance: cardiac arrest location (p = 0.607); and duration of 
cardiopulmonary resuscitation (p = 0.500). 
 
 
 
 
Variables Relative Risk 95% CI p-value 
    
Mean PaCO2 1.50 1.35 - 1.65 <0.001 
Mean PaCO2 squared 0.99 0.99 - 0.99 <0.001 
VT/VF 2.06 1.69 - 2.50 <0.001 
Age* 0.84 0.77 - 0.92 <0.001 
Alveolar dead space† (L/min) 0.90 0.84 - 0.97 0.004 
Metabolic Acidosis‡ 0.60 0.45 - 0.82 0.001 
Mean arterial blood pressure (mmHg) 1.02 1.01 - 1.02 <0.001 
Percutaneous coronary intervention 1.62 1.26 - 2.09 <0.001 
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